Before the "Briefing on Strengthening the Blockade of Harmful Imported Pharmaceuticals Such as Fake Maunza" held on the 17th at the Export and Import Customs Clearance Office of Incheon Airport Customs, a Customs Service employee is exhibiting seized items including fake Maunza. Photo by Yonhap News

Before the "Briefing on Strengthening the Blockade of Harmful Imported Pharmaceuticals Such as Fake Maunza" held on the 17th at the Export and Import Customs Clearance Office of Incheon Airport Customs, a Customs Service employee is exhibiting seized items including fake Maunza. Photo by Yonhap News

View original image

The illegal importation of obesity treatments such as Mounjaro and Wegovy has soared. As of August of this year, the number of seizures by customs authorities increased more than fourfold compared to the total from the previous year. The seizures included counterfeit drugs containing insufficient levels of active ingredients or undisclosed impurities.


According to the Korea Customs Service on September 17, the number of illegal import cases involving obesity treatments surged from 4 cases in 2024 to 1,189 cases last year, and as of August this year, the number had risen to 5,030 cases. This figure is 4.2 times the full-year count from last year.


Mounjaro and Wegovy imported from overseas have been designated by the Ministry of Food and Drug Safety as harmful pharmaceuticals, and may not be brought into the country without meeting the required import procedures, such as acquiring an 'Exemption Recommendation for Import Requirement Verification.'


Over the past three years, a total of 6,223 cases were detected, and when broken down by import route: 4,961 cases came via international mail, 1,232 cases were carried by travelers as personal luggage, and 30 cases arrived as express cargo. Analysis by the Central Customs Laboratory in collaboration with researchers from the College of Pharmacy at Chung-Ang University on Mounjaro products from India that were blocked at customs found significant deviations in the content of the active ingredient tirzepatide. Several samples also contained multiple unidentified impurities. Mounjaro must be refrigerated between 2 and 8 degrees Celsius to maintain its quality, but it was found that these products were transported without any cold chain logistics.


At the export-import clearance building of Incheon Airport Customs on the 17th, a Customs official is unveiling seized counterfeit Mountza and other items ahead of the briefing on strengthening the blocking of harmful overseas imported pharmaceuticals. Photo by Yonhap News

At the export-import clearance building of Incheon Airport Customs on the 17th, a Customs official is unveiling seized counterfeit Mountza and other items ahead of the briefing on strengthening the blocking of harmful overseas imported pharmaceuticals. Photo by Yonhap News

View original image

Nadonghee, Professor at the College of Pharmacy at Chung-Ang University, stated, "Particularly with injectable drugs, not only must the active ingredients and impurities be strictly managed, but aseptic conditions and rigorous manufacturing and quality controls are also mandatory." She added, "It can be hazardous to arbitrarily purchase and use products with unknown origin and quality."



Lee Jinhui, Director General of the Clearance Bureau at Korea Customs Service, said, "As attempts to illegally import various pharmaceuticals, including obesity treatments, are on the rise, we will strengthen inspections according to import route and take strict action against illegal activities such as smuggling."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing